123 related articles for article (PubMed ID: 36701769)
21. Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study Group.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Shamsi HN; Al Suliman SM; Al Rushood AA; Al-Zahrani YA; Al-Mahmood AM; Al Dhibi HA;
Ocul Immunol Inflamm; 2019; 27(8):1296-1304. PubMed ID: 30303435
[No Abstract] [Full Text] [Related]
22. Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Suhler EB; Jaffe GJ; Fortin E; Lim LL; Merrill PT; Dick AD; Brezin AP; Nguyen QD; Thorne JE; Van Calster J; Cimino L; Adan A; Goto H; Kaburaki T; Kramer M; Vitale AT; Kron M; Song AP; Liu J; Pathai S; Douglas KM; Schlaen A; Muccioli C; Van Velthoven MEJ; Zierhut M; Rosenbaum JT
Ophthalmology; 2021 Jun; 128(6):899-909. PubMed ID: 33157077
[TBL] [Abstract][Full Text] [Related]
23. Patterns of Uveitis and Scleritis in Nepal: A Tertiary Referral Center Study.
Manandhar A
Ocul Immunol Inflamm; 2017; 25(sup1):S54-S62. PubMed ID: 27191731
[TBL] [Abstract][Full Text] [Related]
24. Uveitis in Sarcoidosis - Clinical Features and Comparison with Other Non-infectious Uveitis.
Niederer RL; Sharief L; Tomkins-Netzer O; Lightman SL
Ocul Immunol Inflamm; 2023 Feb; 31(2):367-373. PubMed ID: 35201961
[TBL] [Abstract][Full Text] [Related]
25. Outcome of Treating Pediatric Uveitis With Dexamethasone Implants.
Tomkins-Netzer O; Talat L; Seguin-Greenstein S; Bar A; Lightman S
Am J Ophthalmol; 2016 Jan; 161():110-5.e1-2. PubMed ID: 26478217
[TBL] [Abstract][Full Text] [Related]
26. Ocular manifestations of late-onset behçet disease.
Citirik M; Berker N; Songur MS; Ozkan SS; Zilelioglu O
Ophthalmologica; 2011; 225(1):21-6. PubMed ID: 20693818
[TBL] [Abstract][Full Text] [Related]
27. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics of Uveitis in Patients with Psoriasis in Korea: A Retrospective Multicenter Case Series.
Lee Y; Oh BL; Yu HG; Youn SW; Woo SJ
Korean J Ophthalmol; 2021 Feb; 35(1):64-72. PubMed ID: 33307622
[TBL] [Abstract][Full Text] [Related]
29. Outbreak of seasonal hyperacute panuveitis disease in Nepal.
Karn M; Gurung J
Lancet Glob Health; 2022 Jan; 10(1):e39-e40. PubMed ID: 34919853
[No Abstract] [Full Text] [Related]
30. Epidemiology of 2000 Chinese uveitis patients from Northeast China.
Hao T; Yang LI; Li B; Chen X; Li D; Liu X
Br J Ophthalmol; 2021 Mar; 105(3):317-321. PubMed ID: 32424058
[TBL] [Abstract][Full Text] [Related]
31. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
Kempen JH; Van Natta ML; Altaweel MM; Dunn JP; Jabs DA; Lightman SL; Thorne JE; Holbrook JT;
Am J Ophthalmol; 2015 Dec; 160(6):1133-1141.e9. PubMed ID: 26386159
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors in uveitis].
Albaroudi N; Tijani M; Boutimzine N; Cherkaoui O; Laghmari M
J Fr Ophtalmol; 2017 Nov; 40(9):751-757. PubMed ID: 28882393
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and incidence rates of ocular complications in patients with ocular syphilis.
Moradi A; Salek S; Daniel E; Gangaputra S; Ostheimer TA; Burkholder BM; Leung TG; Butler NJ; Dunn JP; Thorne JE
Am J Ophthalmol; 2015 Feb; 159(2):334-43.e1. PubMed ID: 25447116
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.
Lopalco G; Venerito V; Sota J; Rigante D; Guerriero S; Orlando I; Franceschini R; Favale R; Lapadula G; Castelli B; Frediani B; Galeazzi M; La Torre F; Iannone F; Tosi GM; Fabiani C; Cantarini L
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):68-73. PubMed ID: 30582503
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis.
Plskova J; Greiner K; Forrester JV
Am J Ophthalmol; 2007 Jul; 144(1):55-61. PubMed ID: 17601428
[TBL] [Abstract][Full Text] [Related]
36. The Pattern of Uveitis in a Pediatric Population at a Tertiary Center in Thailand.
Seepongphun U; Sittivarakul W; Dangboon W; Chotipanvithayakul R
Ocul Immunol Inflamm; 2023 Jan; 31(1):56-64. PubMed ID: 34686121
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Challenges in PD-1 Inhibitor Induced Panuveitis in a Teenage Girl with Chest Soft Tissue Sarcoma - A Case Report.
Shen Y; Gong Y; Su L
Ocul Immunol Inflamm; 2023 Dec; 31(10):2065-2068. PubMed ID: 37442377
[TBL] [Abstract][Full Text] [Related]
38. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
[TBL] [Abstract][Full Text] [Related]
39. Clinical Features and Course in Patients Diagnosed with Ocular Sarcoidosis without Previously Known Systemic Disease at a Tertiary Referral Center in Turkey.
Kemer Atik B; Altan C; Yargı Özkoçak B; Basarir B
Ocul Immunol Inflamm; 2024 Feb; 32(2):168-174. PubMed ID: 37756621
[TBL] [Abstract][Full Text] [Related]
40. Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.
Suhler EB; Adán A; Brézin AP; Fortin E; Goto H; Jaffe GJ; Kaburaki T; Kramer M; Lim LL; Muccioli C; Nguyen QD; Van Calster J; Cimino L; Kron M; Song AP; Liu J; Pathai S; Camez A; Schlaen A; van Velthoven MEJ; Vitale AT; Zierhut M; Tari S; Dick AD
Ophthalmology; 2018 Jul; 125(7):1075-1087. PubMed ID: 29429764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
